International Stem Cell (ISCO) Return on Equity [ROE] (2011 - 2019)
International Stem Cell (ISCO) recorded Return on Equity [ROE] of -310.05% in Q1 2019, down 104.00 percentage points from -206.05% a year earlier and down 230.02 percentage points from the prior quarter.
Powered by 
Analysis
International Stem Cell (ISCO) Return on Equity [ROE] (2011 - 2019) Analysis & Trends
For FY2018, International Stem Cell reported Return on Equity [ROE] of -92.63%, up 127.74 percentage points from FY2017.
- Annual Return on Equity [ROE] has a three-year change of +182.56 percentage points (FY2015 to FY2018).
- Across earlier years, Return on Equity [ROE] came in at -220.37% in FY2017 (-177.54 pp), -42.83% in FY2016 (+232.36 pp) and -275.20% in FY2015.
- The Q1 2019 figure is the lowest quarterly Return on Equity [ROE] since Q4 2017.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last six quarters, with an average year-over-year change of -149.18 percentage points.
- Per Business Quant, the preceding three quarters came in at -80.03% (Q4 2018), -112.49% (Q3 2018) and -291.04% (Q2 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | International Stem Cell | 2.64 Mn | -1.33 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -310.05% |
| Dec 31, 2018 | -80.03% |
| Sep 30, 2018 | -112.49% |
| Jun 30, 2018 | -291.04% |
| Mar 31, 2018 | -206.05% |
| Dec 31, 2017 | -646.33% |
| Sep 30, 2017 | -358.07% |
| Jun 30, 2017 | 5.29% |
| Mar 31, 2017 | 510.04% |
| Dec 31, 2016 | -55.78% |
| Dec 31, 2015 | -217.05% |
| Sep 30, 2015 | -695.79% |
| Jun 30, 2015 | -1,982.64% |
| Mar 31, 2015 | -10,190.08% |
| Mar 31, 2012 | -281.23% |
| Dec 31, 2011 | -209.43% |
| Sep 30, 2011 | -202.72% |
API Access
International Stem Cell Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();